Biotech News 23 Jul 2025 Tweak to mRNA Vaccine “Recipe” Improves Safety and Efficacy Tweaking the structure of the lipid nanoparticles that deliver mRNA reduces inflammation and boosts effectiveness. As millions of people know… Pantitra
Biotech News 11 Jun 2025 Rapid Biomimetic Nanovaccine for Personalized Cancer Therapy A recent article in Nature Communications describes a nanovaccine platform designed to support the development of personalized cancer vaccines. This approach uses… Pantitra
Biotech News 19 Sep 2024 A new way to reprogram immune cells and direct them toward anti-tumor immunity MIT scientists’ discovery yields a potent immune response, could be used to develop a potential tumor vaccine. In new research… Pantitra
Biotech News 02 Sep 2024 Scientists are on the verge of a big cancer vaccine breakthrough This discovery challenges the previous belief that killer cells attack cancer cells randomly. In Short A peptide derived from the… Pantitra
Biotech News 30 Aug 2024 Newly discovered ‘Holy Grail’ of proteins may lead to cancer vaccine Newly discovered ‘Holy Grail’ of proteins may lead to cancer vaccine Researchers from Western University have discovered a protein that… Pantitra
Biotech News 31 Jul 2024 A historic leap in cancer vaccines – here’s what you need to know The UK’s National Health Service has launched the world’s first trial for a cancer vaccine. One in five people worldwide will get cancer… Pantitra
Biotech News 16 May 2024 New mRNA vaccine for deadly brain cancer triggers a strong immune response COVID-19 vaccine development paves way to a new class of cancer immunotherapy. For the first time, scientists have tested a… Pantitra
Biotech News 20 Mar 2024 New DNA Origami Platform, DoriVac, Opens New Path for Designer Cancer Vaccine Development The central ingredient of therapeutic cancer vaccines is antigens, which are preferentially produced or newly produced (neoantigens) by tumor cells… Pantitra
